Skip to main content

Main navigation

  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Resources for Patients and Families
    • Coalition of Patient Advocacy Groups (CPAG)
    • CPAG Steering Committee
    • Webinar Series: Navigating Rare Disease Clinical Trials
    • Webinar Series: Rare Advocacy Resource Exchange
  • For Researchers
    • Resources for Researchers
    • Clinical Research Training Resources
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • More Training Opportunities
    • NIH Data Sharing
    • Other Rare Disease Initiatives
  • News
    • Latest News
    • Impact Stories
    • Spotlight Newsletter
    • Conference on Clinical Research for Rare Diseases
  • COVID-19 Research
    • COVID-19 Research News
    • Impacts Survey
    • Initial Impacts Survey Results
  • Contact Registry
  • About Us
    • About Us
    • Contact Us
facebook twitter linkedin youtube rss RDCRN Members Login
  • Navigating Rare Disease Clinical Trials
  • Rare Advocacy Resource Exchange
Home
facebook twitter linkedin youtube rss RDCRN Members Login
  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Resources for Patients and Families
    • Coalition of Patient Advocacy Groups (CPAG)
    • CPAG Steering Committee
    • Webinar Series: Navigating Rare Disease Clinical Trials
    • Webinar Series: Rare Advocacy Resource Exchange
  • For Researchers
    • Resources for Researchers
    • Clinical Research Training Resources
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • More Training Opportunities
    • NIH Data Sharing
    • Other Rare Disease Initiatives
  • News
    • Latest News
    • Impact Stories
    • Spotlight Newsletter
    • Conference on Clinical Research for Rare Diseases
  • COVID-19 Research
    • COVID-19 Research News
    • Impacts Survey
    • Initial Impacts Survey Results
  • Contact Registry
  • About Us
    • About Us
    • Contact Us

MPI-CDG

Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC)
Researchers Establish New Consensus Guidelines for Congenital Disorders of Glycosylation
December 07, 2020

Health care providers now have a road map for treating two types of congenital disorders of glycosylation: MPI-CDG and PGM1-CDG. A team of international experts from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) published new guidelines for the diagnosis and management of MPI-CDG and PGM1-CDG in the Journal of Inherited Metabolic Disease.

Frontiers in Congenital Disorders of Glycosylation Consortium
FCDGC
MPI-CDG
PGM1-CDG
Subscribe to MPI-CDG

Footer links

  • Contact Us
  • Website Policies
    • facebook
    • twitter
    • linkedin
    • youtube
    • rss

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.